The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Overview of Bone Morphogenetic Proteins
Abstract
STUDY DESIGN: A literature review was conducted. OBJECTIVES: To review the discovery of the bone morphogenetic proteins and describe the bone morphogenetic protein products that will or may be available for clinical use. SUMMARY OF BACKGROUND DATA: Bone morphogenetic proteins comprise the osteoinductive component of several tissue engineering products in late-stage development as replacements for autogenous bone graft, and for bone augmentation and repair. METHODS: The literature on bone morphogenetic proteins was reviewed. RESULTS: Bone morphogenetic proteins were discovered originally on the basis of their presence in osteoinductive extracts of bone matrix. Molecular cloning of bone morphogenetic proteins demonstrated that they are a family of related differentiation factors, each capable of inducing the formation of new bone tissue when implanted. Two of the molecules in clinical use, recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 (OP-1) are produced in a biotechnology process using recombinant deoxyribonucleic acid technology that offers unlimited supply and substantial control over purity and reproducible activity. A third material, bovine bone morphogenetic protein extract, is extracted from bone, and contains a mixture of bone morphogenetic protein molecules. Each of these molecules, although osteoinductive in vivo, has different physiologic roles and biologic activities in vivo and in vitro. Successful development of a product for use in spinal fusion involves selecting the osteoinductive molecule, the amount of the bone morphogenetic protein required, and the method of delivery, as well as conducting subsequent preclinical and clinical studies to evaluate its efficacy and safety. CONCLUSIONS: On the basis of the data provided in this issue of Spine, some of these bone morphogenetic protein-based products provide for revolutionary therapies in orthopedic practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone: Formation by Autoinduction
Urist, M. R. (1965) · Science · doi:10.1126/science.150.3698.893 · Cited by 5,546
Novel Regulators of Bone Formation: Molecular Clones and Activities
Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kriz, R. W., Hewick, R. M., & Wang, E. A. (1988) · Science · doi:10.1126/science.3201241 · Cited by 3,903
Self-citationBone morphogenetic proteins: multifunctional regulators of vertebrate development.
Hogan, B. L. (1996) · Genes & Development · doi:10.1101/gad.10.13.1580 · Cited by 1,962
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
Winnier, G., Blessing, M., Labosky, P. A., & Hogan, B. L. (1995) · Genes & Development · doi:10.1101/gad.9.17.2105 · Cited by 1,788
Recombinant human bone morphogenetic protein induces bone formation.
Wang, E. A., Rosen, V, D'Alessandro, J. S., Bauduy, M., Cordes, P., Harada, T., Israel, D. I., Hewick, R. M., Kerns, K. M., & LaPan, P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2220 · Cited by 1,523
Luo, G., Hofmann, C., Bronckers, A. L., Sohocki, M., Bradley, A., & Karsenty, G. (1995) · Genes & Development · doi:10.1101/gad.9.22.2808 · Cited by 1,021
Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development
Zhang, H., & Bradley, A. (1996) · Development · doi:10.1242/dev.122.10.2977 · Cited by 983
Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily
Storm, E. E., Huynh, T. V., Copeland, N. G., Jenkins, N. A., Kingsley, D. M., & Lee, S.-J. (1994) · Nature · doi:10.1038/368639a0 · Cited by 854
Celeste, A. J., Iannazzi, J. A., Taylor, R. C., Hewick, R. M., Rosen, V, Wang, E. A., & Wozney, J. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9843 · Cited by 826
Self-citationPadgett, R. W., St. Johnston, R. D., & Gelbart, W. M. (1987) · Nature · doi:10.1038/325081a0 · Cited by 751
Cited by
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
Melanin pigmentation in mammalian skin and its hormonal regulation
Slominski, A., Tobin, D. J., Shibahara, S., & Wortsman, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00044.2003 · Cited by 2,015
Shields, L. B. E., Raque, G. H., Glassman, S. D., Campbell, M., Vitaz, T., Harpring, J., & Shields, C. B. (2006) · Spine · doi:10.1097/01.brs.0000201424.27509.72 · Cited by 689
Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration
Kempen, D. H. R., Lu, L., Heijink, A., Hefferan, T. E., Creemers, L. B., Maran, A., Yaszemski, M. J., & Dhert, W. J. A. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.031 · Cited by 610
Review of bone graft and bone substitutes with an emphasis on fracture surgeries
Sohn, H.-S., & Oh, J.-K. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0157-y · Cited by 526
Metadata
- Authors
- Wozney, J. M.
- Venue
- Spine
- Published
- 2002-08
- Volume
- 27
- Issue
- Supplement
- Pages
- S2-S8
- ISSN
- 0362-2436 (ISSN-L)
- OpenAlex
- W1508777555
- Cited by
- 412
- References
- 42
- FWCI
- 20.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Overview of Bone Morphogenetic Proteins. https://app.cochat.ai/papers/10.1097/00007632-200208151-00002
- The paper
- Wozney, J. M. (2002). Overview of Bone Morphogenetic Proteins. Spine. https://doi.org/10.1097/00007632-200208151-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.